Table 2. Overview of P16, PD-1, PD-L1 expressions and BRAFV600E mutation of PLCH.
Case | Isolated pulmonary group | Extrapulmonary recidivism group | |||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | ||
P16 | + | + | − | + | + | + | |
PD-1 | 5% | 20% | 10% | − | 10% | 10% | |
PD-L1 | − | − | 5% | − | 5% | − | |
BRAFV600E mutation | − | − | − | − | − | + |
PD-1, programmed cell death 1; PD-L1, programmed cell death-ligand 1; PLCH, pulmonary Langerhans cell histiocytosis.